Clinical Trial Update: A Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer [Phase 1]

View source ↗

Summary

Phase I clinical trial update for 61Cu-NODAGA-PSMA in prostate cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 61Cu-NODAGA-PSMA (Copper-61 NODAGA-PSMA)

Snippet

Sponsor: Hoag Memorial Hospital Presbyterian | Conditions: Prostate Adenocarcinoma | Phase 1 | Status: RECRUITING